SK
PFE icon

Sarah Ketterer’s Pfizer PFE Stock Holding History

Sarah Ketterer’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.2M Buy
1,916,801
+2,582
+0.1% +$67.5K 0.5% 40
2026
Q1 		$53.8M Sell
1,914,219
-177,500
-8% -$4.73M 0.66% 34
2025
Q4 		$52.1M Buy
2,091,719
+19,672
+0.9% +$496K 0.72% 35
2025
Q3 		$52.8M Buy
2,072,047
+108,735
+6% +$2.68M 0.7% 33
2025
Q2 		$47.6M Sell
1,963,312
-60,943
-3% -$1.42M 0.75% 27
2025
Q1 		$51.3M Buy
2,024,255
+191,465
+10% +$5.01M 1.07% 23
2024
Q4 		$48.6M Sell
1,832,790
-378,520
-17% -$10.3M 1.11% 26
2024
Q3 		$64M Buy
2,211,310
+207,651
+10% +$6.06M 1.57% 20
2024
Q2 		$56.1M Buy
+2,003,659
New +$55.2M 1.53% 21

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sarah Ketterer's PFE Position: Q2 2026 in Review

Sarah Ketterer increased its Pfizer (PFE) stake by 0.13% in Q2 2026, buying an estimated $67.5K and bringing the position to 1,916,801 shares worth $46.2M. The position accounts for 0.5% of the portfolio, ranked #40.

Sarah Ketterer first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $64M in Q3 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sarah Ketterer held 1,916,801 shares of Pfizer worth $46.2M as of Q2 2026.
  • Sarah Ketterer bought 2,582 Pfizer shares in Q2 2026, an estimated $67.5K.
  • Pfizer made up 0.5% of Sarah Ketterer's portfolio in Q2 2026, its #40 holding.
  • Sarah Ketterer first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
  • Sarah Ketterer's Pfizer position peaked at $64M in Q3 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Causeway Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.